Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-18-005064
Filing Date
2018-07-05
Accepted
2018-07-05 16:31:26
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formfour.html 4  
1 OWNERSHIP DOCUMENT formfour.xml 4 4020
  Complete submission text file 0001171843-18-005064.txt   5381
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 301-366-4841
Neuralstem, Inc. (Issuer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 818 CONNECTICUT AVENUE NW SUITE 1100 WASHINGTON DC 20006
Business Address
OLDAKER WILLIAM CLYDE (Reporting) CIK: 0001397571 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33672 | Film No.: 18940925